the story of glp 1 Reflections on discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions The GLP-1 Story... (a GoggleDocs

In addition, we discuss the most recent evidence-based indications for revascularisation in patients with diabetes as well as the targets for glycaemic control post revascularisation

Studies are lacking on the safety and efficacy of GLP-agonists in decompensated NASH cirrhosis

Fink said that testing is expected to include around 25,000 patients and will take about two years

This helps counteract oxidative stress, reduce melanin production, boost cellular repair, and promote a lighter, healthier skin tone along with better liver function

This was a major factor in the prolonged bear market in sugar in this time

doi: 10.1159/000492350 164 MaSWangD-DMaC-YZhangY-D